| Product ID | 43386-050_3ff4d772-6527-4791-9236-e1a97878a200 |
| NDC | 43386-050 |
| Product Type | Human Prescription Drug |
| Proprietary Name | GaviLyte - N |
| Generic Name | Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate |
| Dosage Form | Powder, For Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-05-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090019 |
| Labeler Name | Lupin Pharmaceuticals,Inc. |
| Substance Name | POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE |
| Active Ingredient Strength | 420 g/438.4g; g/438.4g; g/438.4g; g/438.4g |
| Pharm Classes | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |